肝纤维化的治疗研究进展  

Research Advances of the Treatments in Hepatic Fibrosis

作　　者：张莎莎[1] 吕文良[1] 张旭[2] 陈兰羽[1] 杨广栋[1] 徐晨光[1] 李川[1] 李娟梅[1] 

机构地区：[1]中国中医科学院广安门医院感染疾病科,北京100053 [2]上海交通大学附属上海市第一人民医院

出　　处：《浙江中医药大学学报》2012年第4期471-475,共5页Journal of Zhejiang Chinese Medical University

摘　　要：肝纤维化是慢性肝炎发展至肝硬化的必经病理过程,肝纤维化在一定程度上可以逆转,从而使"慢性肝炎-肝纤维化-肝硬化-肝癌"这条慢性进展过程得以终止。重视肝纤维化的及早治疗,可以极为有效地救治慢性肝病患者,减少社会经济损失。本文将近十年来肝纤维化的治疗研究作以综述。Hepatic fibrosis is the necessary pathological process in the development of chronic hepatitis to liver cirrhosis.In some certain degree,liver fibrosis can be reversed,so that the chronic progress process＂chronic hepatitis-hepatic fibrosis-liver cirrhosis-hepatoma＂ will be terminated.Paying attention to the early treatment of hepatic fibrosis will be a very effective treatment in patients with chronic liver disease,also it can reduce social economic loss.Nearly 10 years of hepatic fibrosis treatment will be summarized as follows.

关 键 词：肝纤维化 治疗 综述 

分 类 号：R575[医药卫生—消化系统]